~~<i id='CF8076CE1D'><strike id='CF8076CE1D'><tt id='CF8076CE1D'><pre id='CF8076CE1D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

fashion

author：explore 2025-09-28 23:11:33 - browse：3

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Mindstrong's demise and the future of mental health care

focus

hotspot

entertainment

focus

leisure time

hotspot

PicturesofSenatorDianneFeinsteinrestbyacondolencebookatCityHallinSanFranciscoonFriday.BenjaminFanjoy

WSS

Menendez indictment could see pharma lose a key ally

Sickle cell gene therapy cures need to be accessible in Africa

Health tech startups drop sharply from 2021 highs

Data show record exodus of life scientists from academia

Digital health funding stays low as a new reality sets in

Cuban government calls US nuclear submarine stop a 'provocative escalation'

leisure time

fashion

focus

Guidelines to prevent youth baseball injuries need more muscle

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Cancer drug shortages should be causing more outrage

How are insurers handling Leqembi and related scans?

23andMe had bad news about my health. I wish a person had delivered it

Data show record exodus of life scientists from academia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Superbugs, antibiotic resistance get scrutiny in congress

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

hotspot

After half a century, Israel moves to evict squatter from his cave home on the beach

Mindstrong's demise and the future of mental health care

Sickle cell gene therapy cures need to be accessible in Africa

Why do women spend more than men on medical expenses?

Listen: Who gets the credit for GLP

Listen: Who gets the credit for GLP

entertainment

focus

leisure time

hotspot